Search research articles
Contact Us
Filters
Showing results (11-20 of 40) with videos related to
Page
of 4
Sort By:
Clinical and Experimental Dermatology
|
April 17, 2025
Grade 3 and Grade 4 Cutaneous toxicities in patients across multiple solid tumour types receiving checkpoint inhibitor therapy: An observational study. The experience of a single large specialist institution
Zaina Sharif, James Larkin, Lisa Pickering, et al.
Cancers
|
August 29, 2024
The Clinical Features and Outcomes of Pseudocirrhosis in Breast Cancer
Edward Phillips, Mantegh Sethi, Surammiya Vasanthakumar, et al.
Breast Cancer Research and Treatment
|
February 4, 2022
Clinical outcomes in patients with triple negative or HER2 positive lobular breast cancer: a single institution experience
Alicia Okines, Tazia Irfan, Bernice Asare, et al.
The Breast Journal
|
August 24, 2017
Development and responses of brain metastases during treatment with trastuzumab emtansine (T-DM1) for HER2 positive advanced breast cancer: A single institution experience
Alicia Okines, Tazia Irfan, Komel Khabra, et al.
Cancer Treatment and Research Communications
|
July 4, 2020
Safety and efficacy of T-DM1 in patients with advanced HER2-positive breast cancer The Royal Marsden experience
Nicolò Matteo Luca Battisti, Frances Rogerson, Karla Lee, et al.
Cancer Treatment Reviews
|
November 24, 2024
Expert recommendations on treatment sequencing and challenging clinical scenarios in human epidermal growth factor receptor 2-positive (HER2-positive) metastatic breast cancer
Rupert Bartsch, David Cameron, Eva Ciruelos, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 4, 2017
Pharmacogenetic Analysis of the UK MRC (Medical Research Council) MAGIC Trial: Association of Polymorphisms with Toxicity and Survival in Patients Treated with Perioperative Epirubicin, Cisplatin, and 5-fluorouracil (ECF) Chemotherapy
Elizabeth Smyth, Shenli Zhang, David Cunningham, et al.
Breast (Edinburgh, Scotland)
|
October 3, 2017
Treatment and prognosis of leptomeningeal disease secondary to metastatic breast cancer: A single-centre experience
Belinda Kingston, Hamzeh Kayhanian, Chloe Brooks, et al.
European Heart Journal. Acute Cardiovascular Care
|
August 28, 2021
Evaluation and management of cancer patients presenting with acute cardiovascular disease: a Consensus Document of the Acute CardioVascular Care (ACVC) association and the ESC council of Cardio-Oncology-Part 1: acute coronary syndromes and acute pericardial diseases
Sofie A Gevaert, Sigrun Halvorsen, Peter R Sinnaeve, et al.
JAMA Oncology
|
February 28, 2017
Mismatch Repair Deficiency, Microsatellite Instability, and Survival: An Exploratory Analysis of the Medical Research Council Adjuvant Gastric Infusional Chemotherapy (MAGIC) Trial
Elizabeth C Smyth, Andrew Wotherspoon, Clare Peckitt, et al.
Page
of 4
Search research articles
Search
Showing results (11-20 of 40) with videos related to
Sort By:
Page
of 4
Clinical and Experimental Dermatology
|
April 17, 2025
Grade 3 and Grade 4 Cutaneous toxicities in patients across multiple solid tumour types receiving checkpoint inhibitor therapy: An observational study. The experience of a single large specialist institution
Zaina Sharif, James Larkin, Lisa Pickering, et al.
Cancers
|
August 29, 2024
The Clinical Features and Outcomes of Pseudocirrhosis in Breast Cancer
Edward Phillips, Mantegh Sethi, Surammiya Vasanthakumar, et al.
Breast Cancer Research and Treatment
|
February 4, 2022
Clinical outcomes in patients with triple negative or HER2 positive lobular breast cancer: a single institution experience
Alicia Okines, Tazia Irfan, Bernice Asare, et al.
The Breast Journal
|
August 24, 2017
Development and responses of brain metastases during treatment with trastuzumab emtansine (T-DM1) for HER2 positive advanced breast cancer: A single institution experience
Alicia Okines, Tazia Irfan, Komel Khabra, et al.
Cancer Treatment and Research Communications
|
July 4, 2020
Safety and efficacy of T-DM1 in patients with advanced HER2-positive breast cancer The Royal Marsden experience
Nicolò Matteo Luca Battisti, Frances Rogerson, Karla Lee, et al.
Cancer Treatment Reviews
|
November 24, 2024
Expert recommendations on treatment sequencing and challenging clinical scenarios in human epidermal growth factor receptor 2-positive (HER2-positive) metastatic breast cancer
Rupert Bartsch, David Cameron, Eva Ciruelos, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 4, 2017
Pharmacogenetic Analysis of the UK MRC (Medical Research Council) MAGIC Trial: Association of Polymorphisms with Toxicity and Survival in Patients Treated with Perioperative Epirubicin, Cisplatin, and 5-fluorouracil (ECF) Chemotherapy
Elizabeth Smyth, Shenli Zhang, David Cunningham, et al.
Breast (Edinburgh, Scotland)
|
October 3, 2017
Treatment and prognosis of leptomeningeal disease secondary to metastatic breast cancer: A single-centre experience
Belinda Kingston, Hamzeh Kayhanian, Chloe Brooks, et al.
European Heart Journal. Acute Cardiovascular Care
|
August 28, 2021
Evaluation and management of cancer patients presenting with acute cardiovascular disease: a Consensus Document of the Acute CardioVascular Care (ACVC) association and the ESC council of Cardio-Oncology-Part 1: acute coronary syndromes and acute pericardial diseases
Sofie A Gevaert, Sigrun Halvorsen, Peter R Sinnaeve, et al.
JAMA Oncology
|
February 28, 2017
Mismatch Repair Deficiency, Microsatellite Instability, and Survival: An Exploratory Analysis of the Medical Research Council Adjuvant Gastric Infusional Chemotherapy (MAGIC) Trial
Elizabeth C Smyth, Andrew Wotherspoon, Clare Peckitt, et al.
Page
of 4